orforglipron semaglutide comparison New GLP pill, orforglipron, versus established GLP pill, in those with obesity & type 2 diabetes. 1️⃣Average blood sugar improved slightly more with (reduced HbA1c by 2.2% from baseline 8.3%) Daily Oral GLP-1 Receptor Agonist

Cortisol Both peptides stimulate the HPA axis through CRF-mediated ACTH release (ACTH releasing activity of KP-102, 2005): Ghigo et al

Race and Renal Impairment in Heart Failure

Evidence suggests RLS runs in families, accounting for about 20% of a person's risk

Retatrutide's glucagon receptor agonism can transiently raise blood glucose, whilst its GLP-1 activity promotes insulin secretion and lowers blood glucose

Patients should be alert to: Persistent constipation , which may increase diverticular pressure New or worsening abdominal pain , especially if localised to the lower abdomen Changes in stool consistency or frequency Fever or systemic symptoms suggesting infection Communication with healthcare providers is vital

In hepatocytes, ZIP14 translocates from the plasma membrane to endosomes during glucose uptake, supplying zinc required for endosomal protease activity and insulin receptor regulation